On March 4, 2010, Sharon-Lise Normand, Director of Mass-DAC, presented the findings of this year's annual reports for CABG and PCI to a joint group of 75 Massachusetts ACC and STS members.

PCI Criteria and Definitions for Identifying Compassionate Use and Exceptional Risk Cases (pdf) Updated March 2010

The Mass-DAC Criteria for Identifying Compassionate Use and Exceptional Risk file provides the the risk factors and definitions for variables used to determine if an individual case should be designated as compassionate use. In addition, the Exceptional Risk designation has additional protocols that need to be followed to qualify a patient procedure as an Exceptional Risk case. We have also provided several cases studies that provide examples of Exceptional Use cases.

Protocol details: ExceptionalRiskv2public.pdf.

Case Studies: ExceptionalRiskCaseStudies200910.pdf.

Mass-DAC December 2010 PCI Data Submission Harvest

Mass-DAC September 2010 PCI Data Submission Harvest

Mass-DAC June 2010 PCI Data Submission Harvest

Dr. Ather Anis presented at the AHA Scientific Sessions 2009 conference recently held in Orlando, Florida. His research found that primary PCI for STEMI at centers without surgery on-site is associated with similar rate of death and MI but increased repeat revascularizations at one year. Dr. Anis used Mass-DAC data for this research. To read more about Dr. Anis's presentation and findings, click here.

Dr. Anis presents "The Impact of Vascular Complications and Advanced Age on Outcomes Following Percutaneous Coronary Intervention," a paper arising out of research by Dr. Alice Jacobs and Mass-DAC.

Dr. Charytan presents "Complex PCI and High Risk Patients: Long-term clinical outcomes following drug-eluting and bare metal stenting in patients with chronic kidney disease in Massachusetts," a paper stemming from research performed by Dr. Laura Mauri in conjunction with Mass-DAC.

"Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison Between Hospitals With and Without Cardiac Surgery On-Site" was accepted as a Late Breaking Clinical Trial abstract at the 2009 American Heart Association Scientific Sessions in Orlando. Authors include Ather Anis, Sharon-Lise Normand, Robert E. Wolf, Ann Lovett, Laura Mauri, Neal Patel, and Alice K. Jacobs.